A new IHME analysis finds 6.9 million deaths worldwide, and suggests countries have been undercounting since the beginning of the pandemic.

Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses the debate over patent protection for COVID-19 vaccines.

The Food and Drug Administration is set to authorize the Pfizer-BioNTech vaccine for use in 12-to-15-year-olds by early next week.

May 4, 2021, 11-11:45 am EDT The Johns Hopkins Health Policy Forum -- a series of discussions with leaders at the forefront of health policy development and implementation

The Food and Drug Administration is preparing to authorize use of the Pfizer-BioNTech coronavirus vaccine in adolescents 12 to 15 years old by early next week.

Jennifer Nuzzo discusses herd immunity and vaccine hesitancy in the United States and how those trends may impact the country's return to "normalcy."

Friday April 30, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Health experts said that people who contract COVID-19 in the middle of their vaccine series should still get the second dose.

Johns Hopkins Center for Health Security Senior Scholar Jennifer Nuzzo discusses the new CDC guidance on when to wear a face mask. 

Friday April 23, 2021 12:00-12:30 ET Join experts from the Johns Hopkins Coronavirus Resource Center (CRC) at 12pm ET on Fridays for timely, accessible updates on the state of the pandemic and the public health response.

Though optimism grows in the U.S. as more and more people get vaccinated, the global picture is far from rosy. 

Virtually all adults in the U.S. who want to get vaccinated will have been able to get a shot by July, yet relatively few children, especially younger children, will have been vaccinated by then.